KDL Biotech Ltd. - Research Center
532291 KOPDRUGS Group (Z) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 14 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Sales |
- |
9.12 |
11.42 |
13.19 |
13.56 |
Operating profit |
-0.61 |
-0.99 |
-1.81 |
-0.99 |
-0.85 |
Interest |
2.45 |
3.45 |
3.41 |
3.42 |
3.33 |
Gross profit |
-2.98 |
-4.25 |
-5.06 |
-4.11 |
-4.01 |
EPS (Rs) |
-2.68 |
-3.20 |
-3.55 |
-3.45 |
-3.73 |
Half yearly
results in details
|
Sep ' 14 |
Mar ' 13 |
Sep ' 12 |
Mar ' 12 |
Sep ' 11 |
Other income |
0.07 |
0.20 |
0.16 |
0.30 |
0.16 |
Stock adjustment |
- |
-0.38 |
- |
- |
- |
Raw material |
- |
0.34 |
0.60 |
0.04 |
0.25 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.18 |
3.90 |
5.03 |
4.95 |
4.85 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
0.43 |
6.26 |
7.60 |
9.19 |
9.31 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
3.46 |
3.44 |
3.46 |
4.21 |
4.95 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-6.44 |
-7.68 |
-8.52 |
-8.28 |
-8.96 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
0.03 |
- |
Equity capital |
24.04 |
24.04 |
24.04 |
24.04 |
24.04 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
74.85 |
74.85 |
74.85 |
74.85 |
74.85 |
Agg.of non promotoholding (%) |
31.14 |
31.14 |
31.14 |
31.14 |
31.14 |
OPM (%) |
- |
-10.89 |
-15.89 |
-7.51 |
-6.26 |
GPM (%) |
- |
-45.56 |
-43.73 |
-30.46 |
-29.23 |
NPM (%) |
- |
-82.45 |
-73.63 |
-61.39 |
-65.28 |